MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: Comparative effectiveness using the Valencia health care information system

Vaccine

Volumn 31, Issue 37, 2013, Pages 3995-4002

  Puig Barbera J ^a   Natividad Sancho, A ^a   Calabuig Perez J ^b   Lluch Rodrigo, J A ^c   Pastor Villalba, E ^c   Martinez Ubeda S ^a   Perez Vilar S ^a   Diez Domingo J ^a  

^a Centro Superior de Investigacion en Salud Publica CSISP   (Spain)

^b Servicio de Análisis de Sistemas de Información Sanitaria Conselleria de Sanitat   (Spain)

^c Dirección General de Investigación y Salud Pública   (Spain)

Author keywords

Aged; Cohort studies; Comparative effectiveness research; Hospitalization; Influenza vaccines; Subunit; Vaccines

Indexed keywords

INFLUENZA VACCINE; MIFAMURTIDE;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

AGED; COHORT STUDIES; COMPARATIVE EFFECTIVENESS RESEARCH; HOSPITALIZATION; INFLUENZA VACCINES; SUBUNIT; VACCINES;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; COHORT STUDIES; COMORBIDITY; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; POLYSORBATES; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; SPAIN; SQUALENE; TREATMENT OUTCOME; VACCINATION;

EID: 84881541669     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.05.070     Document Type: Article

References (34)

1. Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec 2012, 87:461-476.
2. Simonsen L., Fukuda K., Schonberger L.B., Cox N.J. The impact of influenza epidemics on hospitalizations. J Infect Dis 2000, 181:831-837.
3. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
4. Osterholm M.T., Kelley N.S., Sommer A., Belongia E.A. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis 2011, 12:36-44.
5. Gavazzi G., Krause K.H. Ageing and infection. Lancet Infect Dis 2002, 2:659-666.
6. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
7. Monto A.S., Ansaldi F., Aspinall R., McElhaney J.E., Montaño L.F., Nichol K.L., et al. Influenza control in the 21st century: optimizing protection of older adults. Vaccine 2009, 27:5043-5053.
8. Puig Barberà J., González Vidal D. MF59-adjuvanted subunit influenza vaccine: an improved interpandemic influenza vaccine for vulnerable populations. Expert Rev Vaccines 2007, 6:659-665.
9. Huckriede A., Bungener L., Stegmann T., Daemen T., Medema J., Palache A.M., et al. The virosome concept for influenza vaccines. Vaccine 2005, 23(Suppl. 1):S26-S38.
10. Glück R., Mischler R., Finkel B., Que J.U., Scarpa B., Cryz S.J. Immunogenicity of new virosome influenza vaccine in elderly people. Lancet 1994, 344:160-163.
11. Podda A. The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. Vaccine 2001, 19:2673-2680.
12. De Donato S., Granoff D., Minutello M., Lecchi G., Faccini M., Agnello M., et al. Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly. Vaccine 1999, 17:3094-3101.
13. Baldo V., Baldovin T., Pellegrini M., Angiolelli G., Majori S., Floreani A., et al. Immunogenicity of three different influenza vaccines against homologous and heterologous strains in nursing home elderly residents. Clin Dev Immunol 2010, 10.1155/2010/517198.
14. Squarcione S., Sgricia S., Biasio L.R., Perinetti E. Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects. Vaccine 2003, 21:1268-1274.
15. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176:6333-6339.
16. Mannino S., Villa M., Apolone G., Weiss N.S., Groth N., Aquino I., et al. Effectiveness of adjuvanted influenza vaccination in elderly subjects in Northern Italy. Am J Epidemiol 2012, 176:527-533.
17. Puig-Barberà J., Díez-Domingo J., Arnedo-Pena A., Ruiz-García M., Pérez-Vilar S., Micó-Esparza J.L., et al. Effectiveness of the 2010-2011 seasonal influenza vaccine in preventing confirmed influenza hospitalizations in adults: a case-case comparison, case-control study. Vaccine 2012, 30:5714-5720.
18. Berger M.L., Mamdani M., Atkins D., Johnson M.L. Good research practices for comparative effectiveness research: defining, reporting and interpreting nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report - Part I. Value Health 2009, 12:1044-1052.
19. Puig-Barberà J., Pérez-Vilar S., Pastor-Villalba E., Martín-Ivorra R., Pérez-Breva L., Díez-Domingo J. Validity of the vaccine information system to ascertain influenza vaccination status in hospitalized adults in Valencia, Spain. Influenza vaccines for the world 2012, [Poster 143].
20. Portero-Alonso A., Pastor-Villalba E., Martín-Ivorra R., Alguacil-Ramos A.M., López-Maside A., Miralles-Espí M.T., et al. Prevención y vigilancia de la gripe en la Comunitat Valenciana. Temporada 2010-2011. Informe 129. Conselleria de Sanitat. Dirección General de Investigación y Salud Pública 2011, 26. Available at: http://www.sp.san.gva.es/biblioteca/publicacion_dgsp.jsp?cod_pub_ran=75683&tacc=177 [accessed 03.11.12].
21. González Morán F., Muñoz Criado I., Vanaclocha H. Real time information. A necessary tool in epidemiological surveillance. Gac Sanit 2008, 22:162-167. Grupo de trabajo del Análisis de Vigilancia Epidemiológica (AVE) de la Comunidad Valenciana.
22. Puig-Barberà J., Díez-Domingo J., García-de-Lomas J., Ruiz-García M., Larrea-González R., Limón-Ramírez R., et al. Contribution of influenza and other respiratory viruses to hospitalization during the 2011-2012 winter season: a prospective hospital-based active-surveillance study, Valencia, Spain. Influenza vaccines for the world 2012, [Poster 142].
23. Librero J., Ordiñana R., Peiró S. Automated analysis of the quality of the minimum set of basic data. Implications for risk-adjusting systems. Gac Sanit 1998, 12:9-21.
24. Mangtani P., Cumberland P., Hodgson C.R., Roberts J.A., Cutts F.T., Hall A.J. A cohort study of the effectiveness of influenza vaccine in older people, performed using the United Kingdom general practice research database. J Infect Dis 2004, 190:1-10.
25. Sánchez-Cantalejo C., Ocana-Riola R., Fernández-Ajuria A. Deprivation index for small areas in Spain. Soc Indic Res 2008, 89:259-273.
26. Cleves M.A., Gould W.W., Gutierrez R.G., Marchenko Y.V. An introduction to survival analysis using stata 2010, 143-146. Stata Press, College Station, TX. 3rd ed.
27. Haynes R.B., Sackett D.L., Guyatt G.H., Tugwell P. The principles behind the tactics of performing therapeutic trials. Clinical epidemiology: how to do clinical practice research 2006, 173-243. Lippincott Williams & Wilkins, Philadelphia.
28. Council FFIOOM, World HH International ethical guidelines for epidemiological studies 2009, CIOMS, Geneva.
29. Pregliasco F., Mensi C., Serpilli W., Speccher L., Masella P., Belloni A. Immunogenicity and safety of three commercial influenza vaccines in institutionalized elderly. Aging (Milano) 2001, 13:38-43.
30. Ruf B.R., Colberg K., Frick M., Preusche A. Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly. Infection 2004, 32:191-198.
31. de Bruijn I., Meyer I., Gerez L., Nauta J., Giezeman K., Palache B. Antibody induction by virosomal, MF59-adjuvanted, or conventional influenza vaccines in the elderly. Vaccine 2007, 26:119-127.
32. Orenstein E.W., De Serres G., Haber M.J., Shay D.K., Bridges C.B., Gargiullo P., et al. Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol 2007, 36:623-631.
33. Librero J., Peiró S., Leutscher E., Merlo J., Bernal-Delgado E., Ridao M., et al. Timing of surgery for hip fracture and in-hospital mortality: a retrospective population-based cohort study in the Spanish National Health System. BMC Health Serv Res 2012, 12:15.
34. Zhou H., Thompson W.W., Viboud C.G., Ringholz C.M., Cheng P.Y., Steiner C., et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008. Clin Infect Dis 2012, 54:1427-1436.